RQM+ Appoints Ross D. Segan, MD, MBA, FACS, to Board of Directors

Audio By Carbonatix

PITTSBURGH--(BUSINESS WIRE)--Jan 8, 2026--

RQM+, a leading global MedTech service provider (CRO), today announced that Ross D. Segan, M.D., MBA, FACS, has joined its board of directors. Dr. Segan is a physician–executive and MedTech strategist with senior leadership experience at the U.S. Food and Drug Administration (FDA), Johnson & Johnson, Olympus, Covidien, and Vensana Capital, and currently serves as CEO of Medical Scientific Advisors, LLC.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108502609/en/

Ross D. Segan, M.D., MBA, FACS

“Dr. Segan’s leadership at the intersection of clinical practice, regulatory science, and global MedTech innovation is unmatched,” said John Potthoff, Ph.D., chief executive officer of RQM+. “His experience advising regulators, industry leaders, and investors will strengthen RQM+’s ability to help clients navigate complexity and deliver high-impact products to market.”

“RQM+’s clear sense of purpose and respect for the trust placed in our industry by patients and regulators drew me to the board,” said Dr. Segan. “I look forward to contributing my experience to a company that sees quality and regulatory excellence as enablers of lasting impact.”

Michael Farah, partner at Linden Capital, said, “At Linden, we invest in leadership and governance to drive long-term value, and Dr. Segan exemplifies that approach. His experience across clinical care, regulation, and enterprise strategy will be a strong asset as RQM+ continues to scale its platform and impact.”

Dr. Segan’s career spans 20+ clinical specialties and global markets, with a consistent focus on aligning clinical outcomes, regulatory strategy, health economics, and reimbursement to unlock commercial value. He is also active in policy and advocacy through work with AdvaMed and other industry organizations.

About RQM+

RQM+ is a leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product life cycle.

About Jordi Labs, an RQM+ Company

Jordi Labs, an RQM+ company, provides high quality contract analytical services to some of the world’s leading consumer product, polymer, pharmaceutical, and medical device manufacturers. Our team of Ph.D. analytical chemists specializes in chemical identification. One of our core competencies is extractables & leachables testing.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260108502609/en/

CONTACT: Christine Rogers

+1 308-338-2358 | ext. 2358

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA

INDUSTRY KEYWORD: HEALTH HEALTH TECHNOLOGY OTHER SCIENCE CLINICAL TRIALS SCIENCE BIOTECHNOLOGY

SOURCE: RQM+

Copyright Business Wire 2026.

PUB: 01/08/2026 09:00 AM/DISC: 01/08/2026 09:00 AM

http://www.businesswire.com/news/home/20260108502609/en